<html>
<head>PUBMED IDs for RTKN2</head>
<body bgcolor='#C5F0F2'><h1>RTKN2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15504364/'>Identification and characterization of a lymphocytic Rho-GTPase effector: rhotekin-2.</a> October 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/26124677/'>RTKN2 Induces NF-KappaB Dependent Resistance to Intrinsic Apoptosis in HEK Cells and Regulates BCL-2 Genes in Human CD4(+) Lymphocytes.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/26124677/'>RTKN2 Induces NF-KappaB Dependent Resistance to Intrinsic Apoptosis in HEK Cells and Regulates BCL-2 Genes in Human CD4(+) Lymphocytes.</a> January 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23028356/'>Functional variants in NFKBIE and RTKN2 involved in activation of the NF-κB pathway are associated with rheumatoid arthritis in Japanese.</a> January 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24880483/'>miR-1246 releases RTKN2-dependent resistance to UVB-induced apoptosis in HaCaT cells.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26686412/'>Transcriptome profiling of human FoxP3+ regulatory T cells.</a> November 8  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27082503/'>Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells.</a> April 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27081789/'>Knockdown of Rhotekin 2 expression suppresses proliferation and invasion and induces apoptosis in hepatocellular carcinoma cells.</a> April 7  2016<br></body></html>
